• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根据受众总结和交流生存数据:以基于人群的癌症登记数据为例介绍不同测量方法的教程。

Summarizing and communicating on survival data according to the audience: a tutorial on different measures illustrated with population-based cancer registry data.

作者信息

Belot Aurélien, Ndiaye Aminata, Luque-Fernandez Miguel-Angel, Kipourou Dimitra-Kleio, Maringe Camille, Rubio Francisco Javier, Rachet Bernard

机构信息

Cancer Survival Group, Department of Non-Communicable DiseaseEpidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK,

出版信息

Clin Epidemiol. 2019 Jan 3;11:53-65. doi: 10.2147/CLEP.S173523. eCollection 2019.

DOI:10.2147/CLEP.S173523
PMID:30655705
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6322561/
Abstract

Survival data analysis results are usually communicated through the overall survival probability. Alternative measures provide additional insights and may help in communicating the results to a wider audience. We describe these alternative measures in two data settings, the overall survival setting and the relative survival setting, the latter corresponding to the particular competing risk setting in which the cause of death is unavailable or unreliable. In the overall survival setting, we describe the overall survival probability, the conditional survival probability and the restricted mean survival time (restricted to a prespecified time window). In the relative survival setting, we describe the net survival probability, the conditional net survival probability, the restricted mean net survival time, the crude probability of death due to each cause and the number of life years lost due to each cause over a prespecified time window. These measures describe survival data either on a probability scale or on a timescale. The clinical or population health purpose of each measure is detailed, and their advantages and drawbacks are discussed. We then illustrate their use analyzing England population-based registry data of men 15-80 years old diagnosed with colon cancer in 2001-2003, aiming to describe the deprivation disparities in survival. We believe that both the provision of a detailed example of the interpretation of each measure and the software implementation will help in generalizing their use.

摘要

生存数据分析结果通常通过总体生存概率来传达。其他指标能提供更多见解,并可能有助于将结果传达给更广泛的受众。我们在两种数据设定下描述这些替代指标,即总体生存设定和相对生存设定,后者对应于死亡原因不可用或不可靠的特定竞争风险设定。在总体生存设定中,我们描述总体生存概率、条件生存概率和受限平均生存时间(限制在预先指定的时间窗口内)。在相对生存设定中,我们描述净生存概率、条件净生存概率、受限平均净生存时间、每种原因导致的粗死亡概率以及在预先指定的时间窗口内每种原因导致的生命年损失数。这些指标要么在概率尺度上,要么在时间尺度上描述生存数据。详细阐述了每种指标的临床或人群健康目的,并讨论了它们的优缺点。然后,我们通过分析2001 - 2003年诊断为结肠癌的15 - 80岁英格兰男性基于人群登记数据来说明它们的用途,旨在描述生存方面的贫困差异。我们相信,提供每种指标解释的详细示例以及软件实现将有助于推广它们的使用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ed3/6322561/0fe6d2d5d98d/clep-11-053Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ed3/6322561/0fe6d2d5d98d/clep-11-053Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ed3/6322561/0fe6d2d5d98d/clep-11-053Fig1.jpg

相似文献

1
Summarizing and communicating on survival data according to the audience: a tutorial on different measures illustrated with population-based cancer registry data.根据受众总结和交流生存数据:以基于人群的癌症登记数据为例介绍不同测量方法的教程。
Clin Epidemiol. 2019 Jan 3;11:53-65. doi: 10.2147/CLEP.S173523. eCollection 2019.
2
Direct modeling of the crude probability of cancer death and the number of life years lost due to cancer without the need of cause of death: a pseudo-observation approach in the relative survival setting.无需死因信息直接建模癌症死亡的粗概率和因癌症导致的寿命损失年数:相对生存环境下的一种伪观察方法。
Biostatistics. 2022 Jan 13;23(1):101-119. doi: 10.1093/biostatistics/kxaa017.
3
Different survival analysis methods for measuring long-term outcomes of Indigenous and non-Indigenous Australian cancer patients in the presence and absence of competing risks.在存在和不存在竞争风险的情况下,用于衡量澳大利亚原住民和非原住民癌症患者长期预后的不同生存分析方法。
Popul Health Metr. 2017 Jan 17;15(1):1. doi: 10.1186/s12963-016-0118-9.
4
Estimating restricted mean survival time and expected life-years lost in the presence of competing risks within flexible parametric survival models.在存在竞争风险的情况下,使用灵活参数生存模型估计受限平均生存时间和预期寿命损失。
BMC Med Res Methodol. 2021 Mar 11;21(1):52. doi: 10.1186/s12874-021-01213-0.
5
Estimating the crude probability of death due to cancer and other causes using relative survival models.利用相对生存率模型估算癌症及其他死因的粗死亡率。
Stat Med. 2010 Mar 30;29(7-8):885-95. doi: 10.1002/sim.3762.
6
Reference-adjusted and standardized all-cause and crude probabilities as an alternative to net survival in population-based cancer studies.参考调整和标准化全因和粗概率作为基于人群的癌症研究中净生存的替代方法。
Int J Epidemiol. 2020 Oct 1;49(5):1614-1623. doi: 10.1093/ije/dyaa112.
7
Temporal trends in net and crude probability of death from cancer and other causes in the Australian population, 1984-2013.澳大利亚人群中 1984-2013 年癌症和其他原因导致的净死亡率和粗死亡率的时间趋势。
Cancer Epidemiol. 2019 Oct;62:101568. doi: 10.1016/j.canep.2019.101568. Epub 2019 Jul 19.
8
Erratum: Summarizing and Communicating on Survival Data According to the Audience: A Tutorial on Different Measures Illustrated with Population-Based Cancer Registry Data [Corrigendum].勘误:根据受众总结和交流生存数据:以基于人群的癌症登记数据为例说明不同测量方法的教程 [勘误]
Clin Epidemiol. 2020 Aug 19;12:889. doi: 10.2147/CLEP.S273165. eCollection 2020.
9
Non-parametric estimation of reference adjusted, standardised probabilities of all-cause death and death due to cancer for population group comparisons.非参数估计参考调整后、标准化的全因死亡率和癌症死亡率的概率,用于人群比较。
BMC Med Res Methodol. 2022 Jan 6;22(1):2. doi: 10.1186/s12874-021-01465-w.
10
Estimation and modeling of the restricted mean time lost in the presence of competing risks.存在竞争风险时受限平均时间损失的估计和建模。
Stat Med. 2021 Apr;40(9):2177-2196. doi: 10.1002/sim.8896. Epub 2021 Feb 10.

引用本文的文献

1
Comprehensive conditional survival analysis of pancreatic signet ring cell carcinoma: chemotherapy's role and predictive model development using the SEER database.胰腺印戒细胞癌的综合条件生存分析:化疗的作用及利用监测、流行病学与最终结果(SEER)数据库开发预测模型
Discov Oncol. 2025 Jun 12;16(1):1074. doi: 10.1007/s12672-025-02946-w.
2
Prognostic significance of right ventricular dysfunction in heart failure with preserved ejection fraction: a meta-analysis of reconstructed time-to-event data.射血分数保留的心力衰竭中右心室功能障碍的预后意义:对重构的事件发生时间数据的荟萃分析
Echo Res Pract. 2025 May 29;12(1):13. doi: 10.1186/s44156-025-00080-5.
3

本文引用的文献

1
Describing the association between socioeconomic inequalities and cancer survival: methodological guidelines and illustration with population-based data.描述社会经济不平等与癌症生存率之间的关联:方法指南及基于人群数据的例证
Clin Epidemiol. 2018 May 17;10:561-573. doi: 10.2147/CLEP.S150848. eCollection 2018.
2
A flexible and coherent test/estimation procedure based on restricted mean survival times for censored time-to-event data in randomized clinical trials.一种基于受限平均生存时间的灵活一致的测试/估计程序,用于随机临床试验中删失的生存时间数据。
Stat Med. 2018 Jul 10;37(15):2307-2320. doi: 10.1002/sim.7661. Epub 2018 Apr 22.
3
Widening gap in life expectancy between patients with heart failure living in most and least deprived areas: a longitudinal cohort study.
生活在最贫困和最不贫困地区的心力衰竭患者预期寿命差距不断扩大:一项纵向队列研究。
BMC Med. 2025 May 28;23(1):303. doi: 10.1186/s12916-025-04137-4.
4
Monitoring Temporal Trends in Cancer Survival: Choosing Appropriate Standards When Accounting for Age and Other-Cause Mortality Variation Over Time.监测癌症生存的时间趋势:在考虑年龄和随时间变化的其他原因死亡率时选择合适的标准。
Cancer Epidemiol Biomarkers Prev. 2025 Jul 1;34(7):1141-1148. doi: 10.1158/1055-9965.EPI-24-1727.
5
Constructing individualized follow-up strategies for locally advanced esophageal squamous cell carcinoma patients based on dynamic recurrence risk changes.基于动态复发风险变化为局部晚期食管鳞状细胞癌患者构建个体化随访策略。
Sci Rep. 2025 Jan 2;15(1):175. doi: 10.1038/s41598-024-84099-4.
6
Beta-blocker initiation under dobutamine infusion in acute advanced heart failure: a target trial emulation with observational data.急性重度心力衰竭患者在多巴酚丁胺输注期间开始使用β受体阻滞剂:一项基于观察性数据的目标试验模拟研究
Eur Heart J Open. 2024 Jul 4;4(4):oeae054. doi: 10.1093/ehjopen/oeae054. eCollection 2024 Jul.
7
Trends in Net Survival from Vulvar Squamous Cell Carcinoma in Italy (1990-2015).意大利外阴鳞状细胞癌的净生存率趋势(1990 - 2015年)
J Clin Med. 2023 Mar 10;12(6):2172. doi: 10.3390/jcm12062172.
8
Individual frailty excess hazard models in cancer epidemiology.癌症流行病学中的个体脆弱性超额风险模型。
Stat Med. 2023 Mar 30;42(7):1066-1081. doi: 10.1002/sim.9657. Epub 2023 Jan 24.
9
Trends in Liver Cancer Incidence and Survival in Italy by Histologic Type, 2003-2017.2003 - 2017年意大利按组织学类型划分的肝癌发病率和生存率趋势
Cancers (Basel). 2022 Dec 14;14(24):6162. doi: 10.3390/cancers14246162.
10
Association of socioeconomic deprivation with life expectancy and all-cause mortality in Spain, 2011-2013.2011-2013 年西班牙社会经济剥夺与预期寿命和全因死亡率的关系。
Sci Rep. 2022 Sep 16;12(1):15554. doi: 10.1038/s41598-022-19859-1.
An application of restricted mean survival time in a competing risks setting: comparing time to ART initiation by injection drug use.
受限平均生存时间在竞争风险环境下的应用:比较注射吸毒者开始接受抗逆转录病毒治疗的时间。
BMC Med Res Methodol. 2018 Mar 9;18(1):27. doi: 10.1186/s12874-018-0484-z.
4
Sex Differences in Treatments, Relative Survival, and Excess Mortality Following Acute Myocardial Infarction: National Cohort Study Using the SWEDEHEART Registry.急性心肌梗死患者治疗、相对生存率和超额死亡率的性别差异:基于 SWEDEHEART 注册研究的全国队列研究。
J Am Heart Assoc. 2017 Dec 14;6(12):e007123. doi: 10.1161/JAHA.117.007123.
5
Efficiency of two sample tests via the restricted mean survival time for analyzing event time observations.通过受限平均生存时间进行两样本检验以分析事件时间观测值的效率
Biometrics. 2018 Jun;74(2):694-702. doi: 10.1111/biom.12770. Epub 2017 Sep 12.
6
Life expectancy difference and life expectancy ratio: two measures of treatment effects in randomised trials with non-proportional hazards.预期寿命差异和预期寿命比:非比例风险随机试验中治疗效果的两种衡量指标。
BMJ. 2017 May 25;357:j2250. doi: 10.1136/bmj.j2250.
7
On comparison of net survival curves.关于净生存曲线的比较。
BMC Med Res Methodol. 2017 May 2;17(1):79. doi: 10.1186/s12874-017-0351-3.
8
Conditional Survival: An Assessment of the Prognosis of Patients at Time Points After Initial Diagnosis and Treatment of Locoregional Melanoma Metastasis.条件生存:局部区域黑色素瘤转移初始诊断和治疗后时间点患者预后的评估。
J Clin Oncol. 2017 May 20;35(15):1721-1729. doi: 10.1200/JCO.2016.71.9393. Epub 2017 Apr 4.
9
Covariate-Adjusted Restricted Mean Survival Times and Curves.协变量调整后的受限平均生存时间和曲线
J Clin Oncol. 2017 Feb;35(4):465-466. doi: 10.1200/JCO.2016.67.2279. Epub 2016 Oct 24.
10
Analysing population-based cancer survival - settling the controversies.分析基于人群的癌症生存率——解决争议
BMC Cancer. 2016 Dec 3;16(1):933. doi: 10.1186/s12885-016-2967-9.